Identification of EGR1 as a Key Diagnostic Biomarker in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Through Machine Learning and Immune Analysis Xuanlin Wu, Tao Pan, Zhihao Fang, Titi Hui, Xiaoxiao Yu, Changxu Liu, Zihao Guo, Chang Liu Journal of Inflammation Research.2025; Volume 18: 1639. CrossRef
Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis Gina Ryu, Eileen Laurel Yoon, Wankyu Kim, Dae Won Jun Diagnostics.2025; 15(3): 342. CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease, Recent Revision of Terminology and Its Implications Hyo Young Lee, Eileen L. Yoon The Korean Journal of Gastroenterology.2025; 85(2): 126. CrossRef
Association of elevated Alpha-1-Acid glycoprotein with MAFLD prevalence in young and middle-aged women: a cross-sectional study based on NHANES 2017–2020 Yi Xiao, Xian Luo, Yinghao Fu, Haijuan Huang, Qiaoping Gao, Jiansong Liu, Daxin Pang, Xiaolu Liang, Huadi Chen, Hao Xu Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
The emerging phenotype of nonalcoholic fatty liver disease in lean individuals: what’s different? Priyankar Dey Frontiers in Endocrinology.2025;[Epub] CrossRef
Laboratory monitoring in patients with moderate to severe plaque psoriasis Jonathan M. Fenkel, John A. Osborne, April W. Armstrong, Bruce Strober, Linda Stein Gold, Michael Cameron, Mark Lebwohl Journal of Dermatological Treatment.2025;[Epub] CrossRef
Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences Joo Hyun Oh, Dae Won Jun Clinical and Molecular Hepatology.2024; 30(2): 168. CrossRef
Glucose‐lowering drugs and liver‐related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population‐based studies Shaghayegh Khanmohammadi, Amirhossein Habibzadeh, A. B. M. Kamrul‐Hasan, Art Schuermans, Mohammad Shafi Kuchay Diabetic Medicine.2024;[Epub] CrossRef
Exploring the relationship between air pollution, non-alcoholic fatty liver disease, and liver function indicators: a two-sample Mendelian randomization analysis study Qingliang Song, Jinyue Pan, Maoxing Pan, Chuiyang Zheng, Wen Fan, Jianwei Zhen, Dajin Pi, Zheng Liang, Haiyan Shen, Yuanyou Li, Qinhe Yang, Yupei Zhang Frontiers in Endocrinology.2024;[Epub] CrossRef
Waiting for the changes after the adoption of steatotic liver disease Eileen L. Yoon, Dae Won Jun Clinical and Molecular Hepatology.2023; 29(4): 844. CrossRef
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease” Eileen L. Yoon, Dae Won Jun Clinical and Molecular Hepatology.2023; 30(1): 126. CrossRef
First
Prev
